ConductScience.org, home

Paper3486715

Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.

Salup RR and 1 other. Cancer Immunol Immunother, 1986. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease. Papers, record 3486715. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3486715

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2024-04-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salup RRR R
2Wiltrout RHR H

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Ascitic FluidMajor topic
Interleukin-2Major topic
Kidney NeoplasmsMajor topic
T-Lymphocytes, CytotoxicMajor topic
Animals
Disease Models, Animal
Doxorubicin
Female
Immunization, Passive
Injections, Intraperitoneal
Lymphocyte Activation
Male
Mice
Mice, Inbred BALB C
Recombinant Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N01-CO-23910NCI NIH HHSUnited StatesN01CO023910PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16640524Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes.Cancer Res1983https://conductscience.org/library/papers/6640524PubMed
27185419Role of natural killer cells in control of cancer metastasis.Cancer Metastasis Rev1982https://conductscience.org/library/papers/7185419PubMed
34703766A murine renal cell carcinoma.J Natl Cancer Inst1973https://conductscience.org/library/papers/4703766PubMed
47299115Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo.J Immunol1981https://conductscience.org/library/papers/7299115PubMed
53989307Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.J Immunol1985https://conductscience.org/library/papers/3989307PubMed
66164929Interleukin-2 augments natural killer cell activity.Nature1981https://conductscience.org/library/papers/6164929PubMed
76332379Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2.Science1984https://conductscience.org/library/papers/6332379PubMed
86224401The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.Adv Cancer Res1983https://conductscience.org/library/papers/6224401PubMed
94604193Cell-mediated immunity to tumor cells.Adv Cancer Res1974https://conductscience.org/library/papers/4604193PubMed
106194216Activation of nonspecific killer cells by interleukin 2-containing supernatants.J Immunol1983https://conductscience.org/library/papers/6194216PubMed
116984355Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6984355PubMed
126980254Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.J Exp Med1982https://conductscience.org/library/papers/6980254PubMed
137118294Role of NK cells in the control of metastatic spread and growth of tumor cells in mice.Int J Cancer1982https://conductscience.org/library/papers/7118294PubMed
146970768Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.J Immunol1981https://conductscience.org/library/papers/6970768PubMed
156605805Supplement-induced cytotoxic cells (SICC) generated from mouse thymus or spleen cells cultured in the presence of interleukin 2 and/or polyinosinic acid.Cell Immunol1983https://conductscience.org/library/papers/6605805PubMed
166209054Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes.Diagn Immunol1983https://conductscience.org/library/papers/6209054PubMed
176600251
Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
J Immunol1983https://conductscience.org/library/papers/6600251PubMed
186977616Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.J Exp Med1982https://conductscience.org/library/papers/6977616PubMed
197366733Role of NK cells in tumour growth and metastasis in beige mice.Nature1980https://conductscience.org/library/papers/7366733PubMed
206984352Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).Cancer Immunol Immunother1982https://conductscience.org/library/papers/6984352PubMed

See all 27 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
20041482Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.Cancer2010https://conductscience.org/library/papers/20041482PubMed
12698271Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells.Cancer Immunol Immunother2003https://conductscience.org/library/papers/12698271PubMed
2676022Lymphokine activated killer cells.Blut1989https://conductscience.org/library/papers/2676022PubMed
2598180Therapeutic efficacy of human recombinant interleukin-2 (TGP-3) alone or in combination with cyclophosphamide and immunocompetent cells in allogeneic, semi-syngeneic, and syngeneic murine tumors.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2598180PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3486715

GET https://conductscience.org/api/papers/v1/3486715/references?page=2